Showing 5,801 - 5,820 results of 10,374 for search '"Han Chinese', query time: 0.17s Refine Results
  1. 5801
  2. 5802
  3. 5803
  4. 5804

    Systemic Inflammation Markers Associated with Bone Mineral Density in perimenopausal and Postmenopausal Women by Chen Y, Yu J, Shi L, Han S, Chen J, Sheng Z, Deng M, Jin X, Zhang Z

    Published 2023-01-01
    “…Yijie Chen,1,* Jingjing Yu,2,* Lan Shi,1 Shuyang Han,1 Jun Chen,1 Zhumei Sheng,3 Miao Deng,3 Xuejing Jin,1,3 Zhifen Zhang1,3 1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2School of Public Health, Hangzhou Normal University, Hangzhou, People’s Republic of China; 3Department of the Reproductive Endocrinology Division, Hangzhou Women’s Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhifen Zhang; Xuejing Jin, The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, 548 Binwen Road, Binjiang District, Hangzhou, Zhejiang, 310053, People’s Republic of China, Email zhangzf@zju.edu.cn; jxj20210928@163.comObjective: The aim of this research was to determine whether systemic inflammatory indicators, including aggregate index of systemic inflammation (AISI), neutrophils lymphocyte to platelet ratio (NLPR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI), are related to bone mineral density (BMD) in perimenopausal and postmenopausal women.Methods: One hundred and eighty-one perimenopausal and 390 postmenopausal women were enrolled in this cross-sectional study. …”
    Get full text
    Article
  5. 5805
  6. 5806

    Comprehensive Analysis Reveals the Potential Roles of CDKN3 in Pancancer and Verification in Endometrial Cancer by Gao C, Fan X, Liu Y, Han Y, Liu S, Li H, Zhang Q, Wang Y, Xue F

    Published 2023-12-01
    “…Chao Gao,1,2,* Xiangqin Fan,1– 3,* Yanyan Liu,1,2,* Yanyan Han,4,5 Shiqi Liu,1,2 Huanrong Li,1,2 Qiaoling Zhang,1,2 Yingmei Wang,1,2 Fengxia Xue1,2 1Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China; 2Tianjin Key Laboratory of Female Reproductive Health and Eugenics, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China; 3Department of Obstetrics and Gynecology, Zaozhuang Municipal Hospital, Shandong, People’s Republic of China; 4Department of Pathology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, People’s Republic of China; 5National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fengxia Xue; Yingmei Wang, Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, People’s Republic of China, Tel +86-22-60363769, Email xuefengxia@tmu.edu.cn; wangyingmei@tmu.edu.cnBackground: Cyclin-dependent kinase inhibitor 3 (CDKN3) has been studied in many cancers. …”
    Get full text
    Article
  7. 5807
  8. 5808
  9. 5809
  10. 5810
  11. 5811
  12. 5812
  13. 5813
  14. 5814
  15. 5815
  16. 5816
  17. 5817
  18. 5818
  19. 5819
  20. 5820